about
Insect antimicrobial peptides: potential tools for the prevention of skin cancerMatricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsA systems biology view of blood vessel growth and remodellingTumorHoPe: a database of tumor homing peptidesPHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing.A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivoPharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.Inhibition of breast cancer growth and metastasis by a biomimetic peptide.Endostatin inhibits hypertrophic scarring in a rabbit ear model.Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.Computational systems biology approaches to anti-angiogenic cancer therapeutics.A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formationDevelopment of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancerAntiAngioPred: A Server for Prediction of Anti-Angiogenic PeptidesIdentification of the Key Fields and Their Key Technical Points of Oncology by Patent Analysis.Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growthStructure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesCollagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.Constructing the angiome: a global angiogenesis protein interaction network.Cancer treatment using peptides: current therapies and future prospectsTransformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation.Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45AIdentification of Peptides Derived from the C-terminal Domain of Fibulin-7 Active for Endothelial Cell Adhesion and Tube Formation Disruption.From antimicrobial to anticancer peptides. A review.Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.Properdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression.Antiangiogenic and anticancer molecules in cartilage.Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Gene delivery nanoparticles to modulate angiogenesis.Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide.Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.
P2860
Q26740243-81AA3C3F-D52B-441C-904F-E5F94E77F3EEQ26766481-507C1CF8-C744-49D0-8D69-8DF200AC35FEQ27003945-F8E26736-F6C3-49D5-AF16-F2C5C496F777Q28482352-2E04F2E4-4A7E-4FCC-9BC4-865E93F7357DQ28552108-F0E64383-BBC6-4692-B3F4-94CDC23202BFQ30665888-AB7BFF33-1896-441A-BA58-AF298AEDC9B7Q34079689-0B6D2F8F-D35D-4DEE-8BBF-9A3BED021696Q34545644-91CFB87C-119F-48B6-AA54-4AE6D80211E3Q34609617-D4577491-0436-45C8-AC62-73F2758014EEQ34969354-66079FC5-FC66-4533-A524-4DE25FDF5885Q35108084-8148E729-5CBB-46EE-9DB1-8BAAAB1F0DA9Q35407573-BC7A84BB-93A1-41E6-B286-3ED91C53E143Q35501362-DC23F85E-7481-4658-8CDC-91471D3C02E2Q35577780-17D621F6-A5E9-4437-887B-FC08BCCDC542Q35763338-3A8385B1-292D-4C5C-8E71-0F3359C456CCQ35850515-BB82E93D-D6A8-4627-A819-C35F44CB406EQ35882244-5D9C1BA2-55D1-4F42-BD4D-D605413C86EDQ36020002-B2C290B3-4CE5-44EA-B4B9-5FAB09EC51ECQ36062996-C89C1D93-14DB-48AB-911A-51172C9AD272Q36320724-A4E51609-F4D0-4214-B6A0-C5E38A8B3E10Q36515785-59BF54EC-761B-4475-B381-C62B207BEB07Q36531166-E5BC323E-AFFA-4456-95EF-18059D04DC78Q36629386-C395AAAB-98CA-438D-9EA7-79D635DB8A5BQ36827495-58372BFE-0B67-41FF-8736-72D2E1AA8355Q37207728-54D734F1-FFE3-4D1C-A70F-9B0920D07764Q37370299-25E78BE7-6C08-486E-BA9C-C128ACBAD19BQ37401441-54838DEB-5226-40D1-9B97-55635B2E3F38Q37535193-DCE5346D-C50D-417D-AAAB-A41F94F5C91EQ37601970-E0F05DD5-1920-4C7F-BDF7-C10CBD105F64Q37703365-F76FBE6A-A6EC-4B00-94CC-8C516B529E7CQ37706678-F050E73F-CF48-4740-8327-69C4B74A2423Q37718288-D7BC8C26-8074-4DE6-AE9D-649436395BD5Q38007565-34542D61-58AC-471B-A6FC-34C6E5C314AEQ38214156-B13CCF8F-11C7-4D09-84A8-AA4FAEA0D0DDQ38733829-E5C1CF5D-3479-4A1D-BA59-18757522C6EEQ38757723-B3A2FE64-0203-4B38-8D64-D83A820284D7Q39027588-7F1619EA-E903-4930-BDC2-85B056C2F5E1Q39360670-60D21306-A2C6-4F05-9003-40F651CBE1ACQ40086225-4D9DE989-A140-4AAD-A483-D3E40762C672Q41327051-33C5473F-7F11-435C-8DDF-CBFC0B09E7A7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-angiogenic peptides for cancer therapeutics
@en
type
label
Anti-angiogenic peptides for cancer therapeutics
@en
prefLabel
Anti-angiogenic peptides for cancer therapeutics
@en
P2093
P2860
P1476
Anti-angiogenic peptides for cancer therapeutics
@en
P2093
Amir P Tamiz
Corban G Rivera
Elena V Rosca
Jacob E Koskimaki
Niranjan B Pandey
P2860
P304
P356
10.2174/138920111796117300
P577
2011-08-01T00:00:00Z